Aap Implantate AG Stock
Price
Target price
€1.10
€1.10
-2.700%
-0.03
-2.700%
€2.00
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Aap Implantate AG is only available for our menbers.
Not a member yet? Sign up for free!
Not a member yet? Sign up for free!
Financial data and news for Aap Implantate
sharewise wants to provide you with the best news and tools for Aap Implantate, so we directly link to the best financial data sources.
Financials
News
EQS-News: Sales growth Q2/2024 +14 % and H1/2024 +10 % compared to previous year; positive development in all operating areas
EQS-News: Sales growth Q2/2024 +14 % and H1/2024 +10 % compared to previous year; positive development in all operating areas
EQS-News: Amendment of the terms and conditions of the bond completed; Bondholders can convert bonds into shares
EQS-News: Amendment of the terms and conditions of the bond completed; Bondholders can convert bonds into shares
EQS-News: aap closes Q1 2024 with sales growth of 5.6% and positive developments at all operating levels and makes a strong start to Q2 2024
EQS-News: aap closes Q1 2024 with sales growth of 5.6% and positive developments at all operating levels and makes a strong start to Q2 2024
EQS-News: aap successfully places a 10% capital increase from authorized capital at EUR 1.10 with exclusion of subscription rights
EQS-News: aap successfully places a 10% capital increase from authorized capital at EUR 1.10 with exclusion of subscription rights
EQS-Adhoc: aap Implantate AG: aap postpones publication of the consolidated financial statements 2023 due to staff shortages
EQS-Adhoc: aap Implantate AG: aap postpones publication of the consolidated financial statements 2023 due to staff shortages
EQS-News: aap 100% approval of the proposed resolution to amend the terms and conditions of the mandatory convertible bond 2023/2028
EQS-News: aap 100% approval of the proposed resolution to amend the terms and conditions of the mandatory convertible bond 2023/2028
EQS-Adhoc: aap Implantate AG: Capital increase from authorized capital with exclusion of subscription rights
EQS-Adhoc: aap Implantate AG: Capital increase from authorized capital with exclusion of subscription rights
EQS-Adhoc: aap proposes to the bondholders of the mandatory convertible bond 2023/2028 an amendment to the bond terms and conditions to enable the bondholders to exercise their conversion rights earlier
EQS-Adhoc: aap proposes to the bondholders of the mandatory convertible bond 2023/2028 an amendment to the bond terms and conditions to enable the bondholders to exercise their conversion rights earlier
EQS-News: After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year
EQS-News: After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year